Show simple item record

dc.contributor.author Stratan, Maria
dc.date.accessioned 2020-07-11T11:09:34Z
dc.date.available 2020-07-11T11:09:34Z
dc.date.issued 2018
dc.identifier.citation STRATAN, Maria. Genetic aspects of hirsutism. In: MedEspera: the 7th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2018, p. 205-206. en_US
dc.identifier.uri https://medespera.asr.md/wp-content/uploads/Abastract-Book-2018.pdf
dc.identifier.uri http://repository.usmf.md/handle/20.500.12710/11240
dc.description Department of Molecular Biology and Human Genetics, Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova en_US
dc.description.abstract Introduction. Hirsutism is the exaggerated increase of terminal hair in women, developing a male model. Hirsutism is an important medical problem, not just a cosmetic defect, which currently affects about 5-15% of women. The researchers have shown that the impact of hirsutism symptoms on a woman's quality of life can be profound and can lead to psychological stress that threatens her feminine identity. Despite a large number of published works, some aspects of hirsutism are still controversial or underestimated. The treatment of hirsutism often requires a multidisciplinary approach and a variety of physical or pharmacological modalities can be used with the combination of 2 or more drugs in combination with esthetic treatment, depending on the involved etiopathogenetic mechanism. Aim of the study. Evaluation of the molecular-genetic bases of hirsutism, the study of clinical polymorphism and the management of women with hirsutism. Materials and methods. Online databases, meta-analyzes, scientific papers in theoretical and practical medicine were used. Results. Following the analyses of the scientific papers we highlighted the main etiological factors of hirsutism: ovarian (93% PCOS, <1% androgendependent tumors, <1% luteoma); adrenals (<1% CAH, <1% Cushing syndrome, <1% androgen secretory tumors, 1% acromegaly) and other external factors (<1% iatrogenic, <1% androgenic drugs). The genetic approach has noted the involvement in the development of hirsutism of mutations in 5 major genes encoding important enzymes in androgen metabolism: 21-hydroxylase, P450 cytochrome oxidoreductase, aromatase, 11-beta-hydroxylase, 5 alpha reductase. The diagnosis of hirsutism is based on a detailed anamnesis, the objective exam using the Ferriman-Galway scale, seric markers, additional genetic and paraclinical tests. Ovarian suppression of androgens secretion with oral contraceptives is widely used in these women, but its efficacy is limited. One of the most effective medical therapies for hirsutism is medication with anti-androgens (spironolactone, finasteride, flutamide, etc.) Conclusions. Hirsutism is a current medical problem that affects women's quality of life. PCOS (polycystic ovary syndrome) is the most common cause of hirsutism. The management of a woman with hirsutism requires a multidisciplinary approach - family doctor, endocrinologist, gynecologist, dermatologist. The treatment is indicated according to the ethiopathological, individualized mechanism, treatment strategies can be included with the combination of 2 or more drugs. Aesthetic and maintenance treatment is not excluded. en_US
dc.language.iso en en_US
dc.publisher MedEspera en_US
dc.subject hirsutism en_US
dc.subject PCOS en_US
dc.subject Ferriman-Gallwey en_US
dc.subject oral contraceptives en_US
dc.subject anti-androgens en_US
dc.title Genetic aspects of hirsutism en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

  • MedEspera 2018
    The 7th International Medical Congress for Students and Young Doctors, May 3-5, 2018

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics